ANIK EBITDA
Anika Therapeutics Inc · EBITDA
ANIK EBITDA
Latest reported$2.72Mperiod ending
ANIK TTM EBITDA (-$1.50M → $2.72M)
TTM EBITDA
High-resolution chart · PNG
ANIK ebitda history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | EBITDA (USD) |
|---|---|
| 2,720,000 | |
| -4,715,000 | |
| -3,578,000 | |
| 20,869,000 | |
| -3,721,000 | |
| -328,000 | |
| -459,000 | |
| -25,005,000 | |
| -3,079,000 | |
| -3,442,000 | |
| -9,497,000 | |
| -14,205,000 | |
| -12,575,000 | |
| -12,631,000 | |
| -4,105,000 | |
| -5,948,000 | |
| -2,655,000 | |
| -4,046,000 | |
| -4,163,000 | |
| -2,161,000 | |
| -3,860,000 | |
| -4,535,000 | |
| -1,004,000 | |
| 7,896,000 | |
| 21,734,000 | |
| 36,993,000 | |
| 41,270,000 | |
| 46,175,000 | |
| 42,696,000 | |
| 41,772,000 | |
| 27,754,000 | |
| 27,309,000 | |
| 28,694,000 | |
| 34,735,000 | |
| 50,019,000 | |
| 52,922,000 | |
| 56,016,000 | |
| 51,710,000 | |
| 54,341,000 | |
| 58,684,579 | |
| 57,254,693 | |
| 55,255,381 | |
| 50,022,701 | |
| 45,198,668 | |
| 43,559,802 | |
| 47,501,439 | |
| 66,152,486 | |
| 64,715,511 | |
| 62,098,031 | |
| 56,083,706 | |
| 37,092,364 | |
| 36,803,104 | |
| 31,833,399 | |
| 27,611,269 | |
| 24,596,304 | |
| 19,080,874 | |
| 19,989,173 | |
| 17,532,880 | |
| 15,026,499 | |
| 12,394,479 | |
| 9,654,754 | |
| 7,781,226 | |
| 8,402,337 | |
| 9,110,484 | |
| 9,049,100 | |
| 8,787,821 | |
| 8,369,399 | |
| 5,917,733 | |
| 5,232,948 | |
| 4,581,062 | |
| 4,577,447 | |
| 5,380,593 | |
| 6,118,744 | |
| 6,777,520 | |
| 7,406,158 | |
| 5,964,480 | |
| 5,702,212 | |
| 6,069,477 | |
| 5,811,528 | |
| 5,823,718 | |
| 8,056,367 | |
| 8,221,442 | |
| 9,009,000 | |
| 10,612,000 | |
| 8,264,000 | |
| 7,642,000 | |
| 6,933,000 | |
| 5,449,000 | |
| 4,148,000 | |
| 2,815,000 | |
| 1,349,000 | |
| 1,143,649 | |
| 60,005 | |
| -1,014,243 | |
| -2,349,121 | |
| -3,479,896 | |
| -3,871,409 | |
| -5,479,394 | |
| -5,952,637 | |
| -3,338,776 |